Abiramalatha Thangaraj, Thomas Niranjan, Gupta Vijay, Viswanathan Anand, McGuire William
Neonatology, Sri Ramachandra Medical College and Research Institute, Chennai, Tamil Nadu, India.
Cochrane Database Syst Rev. 2017 Sep 12;9(9):CD012413. doi: 10.1002/14651858.CD012413.pub2.
Breast milk alone, given at standard recommended volumes (150 to 180 mL/kg/d), is not adequate to meet the protein, energy, and other nutrient requirements of growing preterm or low birth weight infants. One strategy that may be used to address these potential nutrient deficits is to give infants enteral feeds in excess of 200 mL/kg/d ('high-volume' feeds). This approach may increase nutrient uptake and growth rates, but concerns include that high-volume enteral feeds may cause feed intolerance, gastro-oesophageal reflux, aspiration pneumonia, necrotising enterocolitis, or complications related to fluid overload, including patent ductus arteriosus and bronchopulmonary dysplasia.
To assess the effect on growth and safety of feeding preterm or low birth weight infants with high (> 200 mL/kg/d) versus standard (≤ 200 mL/kg/d) volume of enteral feeds. Infants in intervention and control groups should have received the same type of milk (breast milk, formula, or both), the same fortification or micronutrient supplements, and the same enteral feeding regimen (bolus, continuous) and rate of feed volume advancement.To conduct subgroup analyses based on type of milk (breast milk vs formula), gestational age or birth weight category of included infants (very preterm or VLBW vs preterm or LBW), presence of intrauterine growth restriction (using birth weight relative to the reference population as a surrogate), and income level of the country in which the trial was conducted (low or middle income vs high income) (see 'Subgroup analysis and investigation of heterogeneity').
We used the Cochrane Neonatal standard search strategy, which included searches of the Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 2) in the Cochrane Library; MEDLINE (1946 to November 2016); Embase (1974 to November 2016); and the Cumulative Index to Nursing and Allied Health Literature (CINAHL; 1982 to November 2016), as well as conference proceedings, previous reviews, and trial registries.
Randomised and quasi-randomised controlled trials that compared high-volume versus standard-volume enteral feeds for preterm or low birth weight infants.
Two review authors assessed trial eligibility and risk of bias and independently extracted data. We analysed treatment effects in individual trials and reported the risk ratio and risk difference for dichotomous data, and the mean difference for continuous data, with respective 95% confidence intervals. . We assessed the quality of evidence at the outcome level via the GRADE approach.
We found one eligible trial that included 64 infants. This trial was not blinded. Analysis showed a higher rate of weight gain in the high-volume feeds group: mean difference 6.20 g/kg/d (95% confidence interval 2.71 to 9.69). There was no increase in the risk of feed intolerance or necrotising enterocolitis with high-volume feeds, but 95% confidence intervals around these estimates were wide. We assessed the quality of evidence for these outcomes as 'low' or 'very low' because of imprecision of the estimates of effect and concern about risk of bias due to lack of blinding in the included trial. Trial authors provided no data on other outcomes, including gastro-oesophageal reflux, aspiration pneumonia, necrotising enterocolitis, patent ductus arteriosus, bronchopulmonary dysplasia, or long-term growth and neurodevelopment.
AUTHORS' CONCLUSIONS: We found only very limited data from one small unblinded trial on the effects of high-volume feeds on important outcomes for preterm or low birth weight infants. The quality of evidence is low to very low. Hence, available evidence is insufficient to support or refute high-volume enteral feeds in preterm or low birth weight infants. A large, pragmatic randomised controlled trial is needed to provide data of sufficient quality and precision to inform policy and practice.
仅给予标准推荐量(150至180毫升/千克/天)的母乳,不足以满足早产或低出生体重婴儿生长发育所需的蛋白质、能量及其他营养素。一种可用于解决这些潜在营养不足的策略是给予婴儿超过200毫升/千克/天的肠内喂养量(“高容量”喂养)。这种方法可能会增加营养物质的摄取和生长速度,但存在的担忧包括高容量肠内喂养可能导致喂养不耐受、胃食管反流、吸入性肺炎、坏死性小肠结肠炎,或与液体超负荷相关的并发症,包括动脉导管未闭和支气管肺发育不良。
评估给予早产或低出生体重婴儿高容量(>200毫升/千克/天)与标准容量(≤200毫升/千克/天)肠内喂养对生长及安全性的影响。干预组和对照组的婴儿应接受相同类型的奶(母乳、配方奶或两者皆有)、相同的强化剂或微量营养素补充剂,以及相同的肠内喂养方案(推注、持续输注)和喂养量增加速度。基于奶的类型(母乳与配方奶)、纳入婴儿的胎龄或出生体重类别(极早产或超低出生体重儿与早产或低出生体重儿)、宫内生长受限的存在情况(使用相对于参考人群的出生体重作为替代指标),以及开展试验国家的收入水平(低收入或中等收入与高收入)进行亚组分析(见“亚组分析和异质性研究”)。
我们采用Cochrane新生儿标准检索策略,其中包括检索Cochrane图书馆中的Cochrane对照试验中央注册库(CENTRAL;2017年第2期);MEDLINE(1946年至2016年11月);Embase(1974年至2016年11月);护理及相关健康文献累积索引(CINAHL;1982年至2016年11月),以及会议论文集、既往综述和试验注册库。
比较早产或低出生体重婴儿高容量与标准容量肠内喂养的随机和半随机对照试验。
两位综述作者评估试验的纳入资格和偏倚风险,并独立提取数据。我们分析了各个试验的治疗效果,并报告二分数据的风险比和风险差,以及连续数据的平均差,并给出各自的95%置信区间。我们通过GRADE方法在结局层面评估证据质量。
我们找到一项符合条件的试验,该试验纳入了64名婴儿。该试验未设盲。分析显示高容量喂养组的体重增加率更高:平均差为6.20克/千克/天(95%置信区间2.71至9.